Summary & Overview
CPT 00162: Anesthesia for Head and Neck Procedures
Headline: New Guidance on Anesthesia Code 00162 for Head and Neck Procedures
Lead: CPT 00162 denotes anesthesia services for procedures involving the esophagus, thyroid, larynx, trachea and lymphatic structures of the neck. It captures anesthesiology complexity for a range of head and neck operations and holds relevance for hospital billing, resource allocation, and perioperative planning nationwide.
What this code represents and why it matters: CPT 00162 identifies anesthesia care tied to surgeries and diagnostic procedures in anatomically complex and airway-sensitive regions. Its use affects inpatient service categorization, anesthesia staffing, and hospital billing workflows, and it intersects with related airway and thyroid procedure coding.
Key payers covered: This overview addresses coverage and policy considerations relevant to Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
What readers will learn: The publication summarizes clinical context for anesthesia in head and neck procedures, compares how major commercial payers approach coverage and coding recognition for CPT 00162, and outlines common billing considerations and related procedural codes. It also highlights typical settings and service implications for inpatient hospitals.
Scope and limitations: Service line metadata was not provided. Data not available in the input where applicable will be noted in detailed sections.
CPT Code Overview
CPT 00162 describes anesthesia services provided for procedures on the esophagus, thyroid, larynx, trachea, and lymphatic system of the neck; not otherwise specified. This code is used for anesthesiology care during operative or diagnostic interventions involving the listed anatomical sites. The service type is Anesthesiology and the typical site of service is Inpatient Hospital (POS 21).
Clinical & Coding Specifications
Clinical Context
A patient is admitted to the inpatient hospital for a procedure involving the upper aerodigestive tract and/or lymphatic system of the neck. Common indications include malignancy of the glottis, vocal cord paralysis, or congenital laryngomalacia producing airway compromise, or other respiratory/circulatory symptoms requiring diagnostic or therapeutic airway procedures. The anesthesiology team evaluates the patient preoperatively, documents airway assessment, reviews comorbidities and relevant imaging, and obtains informed consent. Intraoperatively, anesthesia is provided for procedures on the esophagus, thyroid, larynx, trachea, or neck lymphatics using general endotracheal anesthesia or monitored anesthesia care as appropriate. Postoperative care includes extubation planning, airway observation in the post-anesthesia care unit or inpatient ward, and documentation of anesthetic technique and any airway events.
Coding Specifications
-
Modifiers:
-
QS: Monitored anesthesia care service — used when the anesthesia provided is monitored anesthesia care rather than general anesthesia; document the level of sedation/monitoring. -
QX: CRNA service with medical direction by a physician — used when a Certified Registered Nurse Anesthetist provides the anesthesia services under the medical direction of a physician; documentation must support medical direction requirements. -
Provider taxonomies and specialties:
| Taxonomy Code | Specialty |
|---|---|
207L00000X | Anesthesiology |
367500000X | Certified Registered Nurse Anesthetist |
207RA0401X | Anesthesiology Assistant |
Related Diagnoses
-
C32.0— Malignant neoplasm of glottisClinical relevance: Malignancy of the glottis can require diagnostic or therapeutic procedures on the larynx and adjacent structures; anesthesia for these procedures is reported with
00162. -
J38.00— Paralysis of vocal cords and larynx, unspecifiedClinical relevance: Vocal cord or laryngeal paralysis may necessitate airway evaluation or surgical intervention on the larynx or trachea; anesthesia management for these procedures is captured by
00162. -
Q31.5— Congenital laryngomalaciaClinical relevance: Congenital laryngomalacia can cause airway obstruction requiring diagnostic or corrective procedures on the larynx in the inpatient setting; anesthetic services for such procedures are described by
00162. -
R09.89— Other specified symptoms and signs involving the circulatory and respiratory systemsClinical relevance: Non-specific respiratory or circulatory symptoms may prompt evaluation or intervention on the esophagus, larynx, trachea, or neck lymphatics; anesthesia for these procedures is reported with
00162.
Related CPT Codes
| CPT Code | Description |
|---|---|
31500 | Intubation, endotracheal, emergency procedure |
31575 | Laryngoscopy, flexible; diagnostic |
31600 | Tracheostomy, planned (separate procedure) |
60240 | Thyroidectomy, total or complete |
-
31500(Intubation, endotracheal, emergency procedure): May be performed emergently for airway compromise prior to or during procedures on the larynx or trachea; can precede anesthetic management for procedures coded with00162. -
31575(Laryngoscopy, flexible; diagnostic): Diagnostic laryngoscopy may be performed as part of the surgical evaluation or concurrently with procedures on the larynx; may occur in the same episode of care as services reported with00162. -
31600(Tracheostomy, planned (separate procedure)): Tracheostomy may be performed as an alternative airway intervention in patients requiring prolonged airway support; may follow or alter anesthetic planning for procedures on the trachea or neck. -
60240(Thyroidectomy, total or complete): Thyroid surgery of the neck may require anesthesia covered by00162when procedures involve the thyroid and adjacent structures;60240is a related surgical procedure that commonly involves the same operative site and anesthetic considerations.
National Reimbursement Benchmarks
National mean rates show a clear gap between Medicare and commercial averages: BUCA (an average commercial benchmark) posts a mean of $189.70 while Medicare is represented here as $0.00 in the input. This positions BUCA materially higher than the Medicare placeholder and shows commercial payers generally pay more on average than the Medicare value provided.
Rate dispersion (P75 minus P25) varies substantially across payers. Cigna has the widest spread (609.00 - 88.75 = $520.25), followed by BCBS (520.00 - 279.75 = $240.25) and Aetna (440.00 - 40.00 = $400.00). UnitedHealth Group is the tightest (76.00 - 50.33 = $25.67). The table and chart below present the full percentile and mean breakdown for each payer.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska exhibits a wide range in reimbursement rates for CPT code 00162, with Blue Cross Blue Shield showing the largest spread between the 25th and 75th percentiles ($253.88). This indicates significant variability in negotiated rates within the state, especially among the major commercial payers. The rate spread for BUCA is also notable at $274.99, while Aetna, Cigna, and UnitedHealth Group display minimal variation, with their 25th, 50th, and 75th percentiles clustered closely together.
When compared to national averages, Alaska's mean rates for Blue Cross Blue Shield and BUCA are considerably higher, while Cigna and UnitedHealth Group are below their respective national means. The table and chart below present the full breakdown of payer-specific rates for Alaska, highlighting these differences and the overall distribution across the state.
Key Insights for Alaska
- Blue Cross Blue Shield is the highest paying payer for CPT 00162 in Alaska, with a mean rate of $485.47, while UnitedHealth Group is the lowest at $75.12.
- The rate spread in Alaska is substantial, especially for Blue Cross Blue Shield, with a 75th percentile of $626.67 and a 25th percentile of $372.78.
- Compared to national averages, Alaska's mean rates for most payers (except Cigna and UnitedHealth Group) are notably higher, particularly for Blue Cross Blue Shield and BUCA.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.